In vitro susceptibility of Candida species to lactoferrin

Medical Mycology

Volumn 37, Issue 1, 1999, Pages 35-41

  Xu, Y Y ^a   Samaranayake, Y H ^a   Samaranayake, L P ^a   Nikawa, H ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

Candida species; Lactoferrin

Indexed keywords

LACTOFERRIN;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; FUNGICIDAL ACTIVITY; HUMAN; MOUTH; MUCUS; NONHUMAN; SALIVA; SCANNING ELECTRON MICROSCOPY; TIME; YEAST;

ANIMALS; CANDIDA; CANDIDIASIS, ORAL; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LACTOFERRIN; MICROBIAL SENSITIVITY TESTS;

BOVINAE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; ISSATCHENKIA ORIENTALIS; PICHIA GUILLIERMONDII;

EID: 0033023416     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1999.00198.x     Document Type: Article

References (33)

1. Odds FC, Brawner DL, Staudinger J, Magee PT, Soll DR. Typing of Candida albicans strains. J Med Vet Mycol 1992; 3: 87-94.
2. Samaranayake LP. Host factors and oral candidosis. In: Samaranayake LP, MacFarlane TW, eds. Oral Candidosis, 1st edn., Wright, London, 1990; 66-103.
3. Tenovuo J, Lumikari M, Soukka T. Salivary lysozyme, lactoferrin and peroxidases. Antibacterial effect on cariogenic bacteria and clinical application in preventive dentistry. Proc Finn Dent Soc 1991; 87: 197-208.
4. 2+. J Gen Microbiol 1990; 136: 1437-1446.
5. Massons P, Heremans J. Studies on lactoferrin, the iron binding protein of secretions. Prot Biol Fluids 1966; 14: 115-124.
6. Massons P, Heremans J, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med 1969; 130: 643-658.
7. Mazurier J, Spik G. Comparative studies of the iron-binding properties of human transferrins. Biochem Biophys Acta 1980; 45: 413-421.
8. Cole MF, Arnold R, Mestecky J, Kulhavy R, McGhee JR. Studies with human lactoferrin and Streptococcus mutans. In: Stiles H, Loesche W, O'Brien T, eds. Microbial Aspects of Dental Caries II., Information Retrieval, Washington, DC, 1976; 274-359.
9. Tenovuo J. Nonimmunoglobulin defense factors in human saliva. In: Tenovuo J, ed. Human Saliver: Clinical Chemistry and Microbiology Vol II., CRC press, Boca, Raton, FL, 1989; 55-91.
10. Weinberg ED. Iron and infection. Microbiol Rev 1978; 42: 45-66.
11. Arnold RR, Cole MF, McGhee JR. A bactericidal effect of human lactoferrin. Science 1977; 197: 263-265.
12. Pollock JJ, Denepitiya L, Mackay BJ, Iacono VJ. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun 1984; 44: 702-707.
13. Arnold RR, Ruddell JE, Champion WJ, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: differentiation from the stasis of iron deprivation. Infect Immun 1982; 35: 792-799.
14. Lassiter MO, Newsome AL, Sams LD, Arnold RR. Characterization of lactoferrin interaction with Streptococcus mutans. J Dent Res 1987; 66: 480-485.
15. Arnold RR, Russell JE, Champion WJ, Gauthier JJ. Bactericidal activity of human lactoferrin: influence of physical condition and metabolic state of the target microorgmism. Infect Immun 1981; 32: 655-660.
16. Kalmar JR, Arnold RR. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun 1988; 56: 2552-2557.
17. Valenti P, Visca P, Antonini G, Orsi N. Interaction between lactoferrin and ovotransferrin and Candida cells. FEMS Microbiol Letts 1986; 33: 271-275.
18. Soukka T, Tenovuo J, Lenander-Lumikari M. Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol Letts 1992; 90: 223-228.
19. Nikawa H, Samaranayake LP, Tenovuo J, Pand KM, Hamada T. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. Archs Oral Biol 1993; 38: 1057-1063.
20. Samaranayake YH, Samaranayake LP, Wu PC, So M. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans. Acta Pathol Microbiol Immunol Scand 1997; 105: 875-883.
21. Silverman S, Migliorati M, Epstein J, Samaranayake LP. Laboratory diagnosis of oral candidosis. In: Samaranayake LP, MacFarlane TW. eds. Oral Candidosis, 1st edn., Wright, London, 1990; 213-217.
22. Walther P, Chen Y, Pech LL, Pawley JB. High-resolution scanning electron microscopy of frozen-hydrated cells. J Microsc 1992; 168: 169-180.
23. Anders T, Fejerskov O. Textbook of Cardiology., Munksgaard, Copenhagen, 1986.
24. Kamaya T. Lytic action of lysozyme on Candida albicans. Mycopathol Mycol Applic 1970; 42: 197-207.
25. Kirkpatrick CH, Green I, Rich RR, Schade AL. Inhibition of growth of Candida albicans by iron-unsaturated lactoferrin: Relation to host defense mechanisms in chronic mucocutaneous candidiasis. J Infect Dis 1971; 124: 539-544.
26. Samaranayake YH, MacFarlane TW, Aitchison TC, Samaranayake LP. The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media. Oral Microbiol Immunol 1993; 8: 177-181.
27. Samaranayake YH, MacFarlane TW, Samaranayake LP, Aitchison TC. The in vitro lysozyme susceptibility of Candida species cultured in sucrose supplemented media. Microbios 1993; 74: 23-28.
28. MacFarlane TW. Ecology and Epidemiology of Candida. In: Samaranayake LP, MacFarlane TW, eds. Oral Candidosis, 1st edn., Wright, London, 1990; 21-46.
29. Tobgi RS, Samaranayake LP, MacFarlane TW. The in vitro susceptibility of Candida species to lysozyme. Oral Microbiol Immunol 1987; 2: 1-4.
30. Laible NJ, Germaine GR. Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides. Infect Immun 1985; 48: 720-728.
31. Lassiter MO, Newsome AL, Sams LD, Arnold RR. Characterization of lactoferrin interaction with Streptococcus mutans. J Dent Res 1987; 66: 480-485.
32. Ellison RT, Giehl TJ, LaForce FM. Damage of the outer membrane of enteric gram negative bacteria by lactoferrin and transferrin. Infect Immun 1988; 56: 2774-2881.
33. Bellamy W, Wakabayashi H, Takase M, Kawase K, Shimamaura S, Tomita M. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med Microbiol Immunol 1993; 182: 97-105.